182 related articles for article (PubMed ID: 2892382)
1. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
[TBL] [Abstract][Full Text] [Related]
6. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
[TBL] [Abstract][Full Text] [Related]
8. Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
Färber I; Klinger C; Wutzler P; Thiel KD; Reefschläger J; Herrmann G
Acta Virol; 1987 Jan; 31(1):13-8. PubMed ID: 2883852
[TBL] [Abstract][Full Text] [Related]
9. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P
Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299
[TBL] [Abstract][Full Text] [Related]
10. Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells.
Ayisi NK; Wall RA; Wanklin RJ; Machida H; De Clercq E; Sacks SL
Mol Pharmacol; 1987 Apr; 31(4):422-9. PubMed ID: 3472064
[TBL] [Abstract][Full Text] [Related]
11. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
[TBL] [Abstract][Full Text] [Related]
12. Oral antiviral drugs in experimental herpes simplex keratitis.
Kaufman HE; Varnell ED; Centifanto-Fitzgerald YM; De Clercq E; Kissling GE
Antimicrob Agents Chemother; 1983 Dec; 24(6):888-91. PubMed ID: 6318664
[TBL] [Abstract][Full Text] [Related]
13. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
Trousdale MD; Dunkel EC; Nesburn AB
Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
[TBL] [Abstract][Full Text] [Related]
14. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Reefschläger J; Bärwolff D; Herrmann G; Langen P
Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
[TBL] [Abstract][Full Text] [Related]
15. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir--a promising antiviral agent: a review of the preclinical and clinical data in ocular herpes simplex management.
Koliopoulos J
Ann Ophthalmol; 1984 Jan; 16(1):19-24. PubMed ID: 6322661
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
Machida H; Ikeda T; Ashida N
Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
Colin C; Chastel C; Quillien MC; Renard G
J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
[TBL] [Abstract][Full Text] [Related]
20. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P
Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
